NovaBridge Biosciences Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NovaBridge Biosciences stock issued during period, value, stock options exercised for the quarter ending 2020-12-31 was 6.98M CNY.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $200.00K 20-F · filed 2026-04-07 | |
| 2023-12-31 | 2.79M CNY 20-F · filed 2024-04-30 | |
| 2023-12-31 | $407.00K 20-F · filed 2026-04-07 | |
| 2022-12-31 | 44.65M CNY 20-F · filed 2024-04-30 | |
| 2022-12-31 | $6.92M 20-F · filed 2025-04-03 | |
| 2021-12-31 | 51.31M CNY 20-F · filed 2024-04-30 | |
| 2020-12-31 | 6.98M CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | 7.77M CNY 20-F · filed 2023-05-01 |